"At Tacoma/Valley Radiation Oncology Centers we're passionate about our patients. Our caring, highly trained team will treat you like family while providing you with the most advanced treatment planning, sophisticated, cutting-edge radiation therapies and the highest level of quality, personalized care. Our radiation therapy services are available in five convenient locations in Tacoma, Puyallup, Gig Harbor and Olympia, thus providing peace of mind that first-rate services are within your reach."

During the past decade, Tacoma/Valley Radiation Oncology Centers-Jackson Hall conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 21 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 18 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tacoma/Valley Radiation Oncology Centers-Jackson Hall" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NRG Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tacoma/Valley Radiation Oncology Centers-Jackson Hall" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Tacoma/Valley Radiation Oncology Centers-Jackson Hall" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Colorectal Cancer" (3 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Tacoma/Valley Radiation Oncology Centers-Jackson Hall" in a lesser frequency.

Most popular intervention types in "Tacoma/Valley Radiation Oncology Centers-Jackson Hall" are "Drug" (37 trials), "Other" (37 trials), "Biological" (17 trials), "Procedure" (11 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (11 trials), "Computed Tomography" (7 trials), "Nivolumab" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Tacoma/Valley Radiation Oncology Centers-Jackson Hall" are 35 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Tacoma/Valley Radiation Oncology Centers-Jackson Hall". undefined are not yet recruiting, 5 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Tacoma/Valley Radiation Oncology Centers-Jackson Hall, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tacoma/Valley Radiation Oncology Centers-Jackson Hall, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".